Strong Signs for a Weak Wall in Tricuspid Aortic Valve Associated Aneurysms and a Role for Osteopontin in Bicuspid Aortic Valve Associated Aneurysms.
Actins
/ metabolism
Adult
Aged
Aortic Aneurysm, Thoracic
/ etiology
Aortic Valve
/ abnormalities
Bicuspid Aortic Valve Disease
Calcinosis
Female
Fibroblasts
/ metabolism
Gene Expression
Heart Valve Diseases
/ metabolism
Humans
Immunohistochemistry
Male
Middle Aged
Myocytes, Smooth Muscle
/ metabolism
Osteopontin
/ genetics
Tricuspid Valve
/ metabolism
alpha smooth muscle actin
atherosclerosis
bicuspid
focal elastic fiber loss
osteopontin
tricuspid
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
26 Sep 2019
26 Sep 2019
Historique:
received:
11
09
2019
accepted:
22
09
2019
entrez:
29
9
2019
pubmed:
29
9
2019
medline:
12
2
2020
Statut:
epublish
Résumé
Central processes in the pathogenesis of TAV- (tricuspid aortic valve) and BAV- (bicuspid aortic valve) associated ascending thoracic aortic aneurysm (ATAA) development are still unknown. To gain new insights, we have collected aortic tissue and isolated smooth muscle cells of aneurysmal tissue and subjected them to in situ and in vitro analyses. We analyzed aortic tissue from 78 patients (31 controls, 28 TAV-ATAAs, and 19 BAV-ATAAs) and established 30 primary smooth muscle cell cultures. Analyses included histochemistry, immuno-, auto-fluorescence-based image analyses, and cellular analyses including smooth muscle cell contraction studies. With regard to TAV associated aneurysms, we observed a strong impairment of the vascular wall, which appears on different levels-structure and dimension of the layers (reduced media thickness, increased intima thickness, atherosclerotic changes, degeneration of aortic media, decrease of collagen, and increase of elastic fiber free area) as well as on the cellular level (accumulation of fibroblasts/myofibroblasts, and increase in the number of smooth muscle cells with a reduced alpha smooth muscle actin (α-SM actin) content per cell). The pathological changes in the aortic wall of BAV patients were much less pronounced-apart from an increased expression of osteopontin (OPN) in the vascular wall which stem from smooth muscle cells, we observed a trend towards increased calcification of the aortic wall (increase significantly associated with age). These observations provide strong evidence for different pathological processes and different disease mechanisms to occur in BAV- and TAV-associated aneurysms.
Identifiants
pubmed: 31561491
pii: ijms20194782
doi: 10.3390/ijms20194782
pmc: PMC6802355
pii:
doi:
Substances chimiques
Actins
0
Osteopontin
106441-73-0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : B. Braun Melsungen
ID : BBST-D-16-00013
Organisme : Tyrolean Science Fund
ID : TWF-2016-1-9
Références
Circulation. 2002 Aug 20;106(8):900-4
pubmed: 12186790
Arterioscler Thromb Vasc Biol. 2000 May;20(5):1177-8
pubmed: 10807728
Eur J Cardiothorac Surg. 2003 Apr;23(4):537-43
pubmed: 12694773
J Thorac Cardiovasc Surg. 2008 Jan;135(1):8-18, 18.e1-2
pubmed: 18179910
Atherosclerosis. 2014 Feb;232(2):361-8
pubmed: 24468149
Eur J Cardiothorac Surg. 2013 Jun;43(6):e180-6
pubmed: 23248206
Mol Cell Proteomics. 2013 Feb;12(2):407-25
pubmed: 23184916
Hum Pathol. 2008 Mar;39(3):437-43
pubmed: 18261628
Atherosclerosis. 2012 Feb;220(2):355-61
pubmed: 22178424
Chest. 2005 Sep;128(3):1580-6
pubmed: 16162761
Cell Physiol Biochem. 2018;48(4):1638-1651
pubmed: 30077999
J Am Coll Cardiol. 2003 Sep 17;42(6):1076-83
pubmed: 13678934
Nat Rev Cardiol. 2009 Dec;6(12):771-86
pubmed: 19884902
Cardiovasc Res. 2005 May 1;66(2):324-33
pubmed: 15820201
Circ Res. 2005 Apr 15;96(7):717-22
pubmed: 15831823
Heart. 2002 Oct;88(4):321-2
pubmed: 12231576
J Clin Pathol. 2008 Apr;61(4):519-23
pubmed: 17938162
Circ Res. 1999 Feb 5;84(2):166-78
pubmed: 9933248
Ann Thorac Surg. 2002 Jul;74(1):58-62
pubmed: 12118804
J Thorac Cardiovasc Surg. 2014 Mar;147(3):1056-64
pubmed: 23764410
Circulation. 2005 Aug 23;112(8):1098-105
pubmed: 16116068
J Heart Valve Dis. 2003 Jan;12(1):54-9; discussion 59-61
pubmed: 12578337
J Biomech. 2014 Dec 18;47(16):3820-4
pubmed: 25468299
Am J Pathol. 2009 Oct;175(4):1746-56
pubmed: 19729479
Circulation. 2008 Jun 3;117(22):2938-48
pubmed: 18519861
J Mol Cell Cardiol. 2019 Aug;133:76-85
pubmed: 31152748
Am Heart J. 2011 Jul;162(1):38-46.e1
pubmed: 21742088
Matrix Biol. 2000 Dec;19(7):615-22
pubmed: 11102750
Arterioscler Thromb Vasc Biol. 2015 Apr;35(4):973-80
pubmed: 25745062
J Exp Med. 2002 Oct 21;196(8):1047-55
pubmed: 12391016
Circulation. 2003 Sep 9;108 Suppl 1:II291-4
pubmed: 12970248
Front Endocrinol (Lausanne). 2012 Aug 06;3:95
pubmed: 22888324
Am J Hum Genet. 2009 May;84(5):617-27
pubmed: 19409525
MethodsX. 2015 Feb 21;2:124-34
pubmed: 26150980
Aorta (Stamford). 2013 Jun 01;1(1):13-22
pubmed: 26798668
J Thorac Cardiovasc Surg. 1999 Oct;118(4):588-94
pubmed: 10504620
Am J Cardiol. 2011 Dec 1;108(11):1639-44
pubmed: 22077975
Circulation. 2005 Feb 15;111(6):816-28
pubmed: 15710776
Mol Med. 2011;17(11-12):1365-73
pubmed: 21968790
Heart. 2010 Jun;96(12):979-85
pubmed: 20538675